Gara Jalqabaatti › Dhukkuba Kroonii › Massachusetts
Qorannoo klinikaalii Dhukkuba Kroonii Massachusetts keessatti
Qorannoo 27 Dhukkuba Kroonii f Massachusetts keessatti hirmaatuu jiru.
Magaalota Massachusetts keessatti
Takkalaa qorannoo (Ingiliffa)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Lucida Clinical Trials /ID# 282000, New Bedford
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07697456Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Massachusetts General Hospital Cancer Center, Boston
- Dana-Farber Cancer Institute, Boston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07033208A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Massachusetts General Hospital-Crohn's and Colitis Center ( Site 5037), Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT06430801A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastro Health Research - Framingham, Framingham
- Lucida Clinical Trials LLC, New Bedford
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Lucida Clinical Trials /ID# 266548, New Bedford
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06548542A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Boston Childrens Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Lucida Clinical Trials, New Bedford
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Tufts Medical Center-Site Number: 8400126, Boston
- UMass Memorial Medical Center-Site Number: 8400121, Worcester
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 16 hanga 80 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT07184931A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Massachusetts General Hospital - Mass General Waltham /ID# 255767, Waltham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 23-Ful-2026 · NCT05995353A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Boston Children's Hospital, Boston
- Massachusetts General Hospital, Waltham
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 19 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Boston Children's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05509777Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Hag-2026 · NCT07237516Low Dose IL-2 for the Treatment of Crohn's Disease
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 03-Hag-2026 · NCT04263831Cranberry and Gut Health in Crohn's Disease
- UMASS medical center, Worcester
Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 hanga 65 · Saalaa hunda · Haaromfame 20-Ado-2026 · NCT07170462Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
- Boston Children's Hospital /ID# 262191, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 24-Wax-2026 · NCT06332534Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Boston Children's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 4
Umuriin 6 hanga 17 · Saalaa hunda · Haaromfame 27-Cam-2026 · NCT05781152A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Boston Children's Hospital, Boston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 2 hanga 17 · Saalaa hunda · Haaromfame 05-Cam-2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Lucida Clinical Trials, LLC, New Bedford
- University of Massachusetts, Worcester, Worcester
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Elb-2026 · NCT06456593A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400022, Boston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 27-Bit-2026 · NCT06958536Value of PET/MR Enterography in the Assessment of Crohn's Disease Using a Collagen-binding Radiotracer.
- Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 12-Bit-2026 · NCT06252493Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 14 fi ol · Saalaa hunda · Haaromfame 30-Ama-2026 · NCT05332639A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 16-Mud-2025 · NCT07219537Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- Boston Children's Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 13 hanga 20 · Saalaa hunda · Haaromfame 30-Onk-2025 · NCT04508088High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy
- Boston Children's Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 5 hanga 25 · Saalaa hunda · Haaromfame 03-Bit-2025 · NCT04331639Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
- Massachusetts General Hospital, Boston
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 14 fi ol · Saalaa hunda · Haaromfame 20-Mud-2024 · NCT06655415Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.